Treatment of Lower Extremity Spider Veins With Excel V

Exclusion Criteria

• •Having received any prior laser treatment for lower extremity spider veins
• •Fitzpatrick Skin Type IV - VI
• •Pregnant
• •Having an infection, dermatitis or a rash in the treatment area
• •Having significant varicosities or perforator veins
• •History of keloid scarring, hypertrophic scarring or of abnormal wound healing
• •History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications
• •History of connective tissue disease, such as systemic lupus erythematosus or scleroderma
• •History of pigmentary disorders, particularly tendency for hyper- or hypo-pigmentation
• •Having a known anticoagulative condition or taking anticoagulation medications
• •History of thromboembolic disease, such as deep vein thrombosis (DVT)
• •History of seizure disorders due to light
• •Having a history of diseases stimulated by heat, such as recurrent herpes simplex in the treatment area, unless treatment is conducted following a prophylactic regimen
• •Having undergone any surgery in the treatment area within 6 months of treatment (or more if skin has not healed completely)
• •Suffering from significant concurrent illness, such as insulin-dependent diabetes (type I or II), peripheral vascular disease or peripheral neuropathy
• •Undergoing systemic chemotherapy for the treatment of cancer
• •Systemic use of isotretinoin (Accutane®) within 6 months of study participation
• •Any use of gold therapy for disorders such as rheumatologic disease or lupus
• •Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning during the study
• •Participation in a study of another device or drug within three months prior to enrollment or during the study
• •As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study